TrialClinical pharmacology in drug development2025

A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High-Concentration, Long-Acting Cabotegravir Formulation in Adults Without HIV.

Kelong Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.